Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)

Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis) Health Canada reviewed the potential risk of severe bone damage (osteonecrosis) with bisphosphonate use because of product information updates in Europe that warn about the risk of severe bone damage in the outer part of the ear canal. Previously, Health Canada completed a safety review of the risk of severe jawbone damage associated with bisphosphonate use. Therefore, the current safety review focused on severe bone damage other than to the jawbone. 2024-05-08 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetySummary Safety ReviewBisphosphonatesassessingpotential riskSevere Bone Damageosteonecrosisproduct informationear canaljawbone damage Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-bisphosphonates-assessing-potential-risk-severe-bone.html Summary Safety Review - Bisphosphonates - Assessing the Potential Risk of Severe Bone Damage (osteonecrosis)HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-bisphosphonates-evaluation-risque-potentiel-lesions-osseuses.html

Health Canada reviewed the potential risk of severe bone damage (osteonecrosis) with bisphosphonate use because of product information updates in Europe that warn about the risk of severe bone damage in the outer part of the ear canal. Previously, Health Canada completed a safety review of the risk of severe jawbone damage associated with bisphosphonate use. Therefore, the current safety review focused on severe bone damage other than to the jawbone.

Data and Resources

Similar records